PAPER Ghosh P, Mukhopadhyay S, Kandasamy T, Mondal S, Ghosh SS, Iyer PK

Multifunctional hydroxyquinoline-derived turn-on fluorescent probe for Alzheimer's disease detection and therapy.

J Mater Chem B. 2025 Jan 22;13(4):1412-1423. PubMed.

PAPER Panzavolta A, Cavallieri F, Valzania F, Radefeldt M, Lemke S, Paul JJ, Curado F, Bauer P, Beetz C, Cerami C

Genetic evidence for a link between frontotemporal dementia and Parkinson's disease: the case of RAB32 Ser71Arg.

J Neurol. 2024 Dec 16;272(1):72. PubMed.

PAPER Liu M, Cai Y, Pan J, Wang T, Li Y, Yu Q, Mao W, Chan P

Serum neurofilament light chain as a diagnostic and prognostic biomarker in multiple system atrophy: a prospective cohort study.

J Neurol. 2024 Dec 16;272(1):74. PubMed.

PAPER Tam J, Centola J, Kurucu H, Watson N, MacKenzie J, Green A, Summers D, Barria M, Seth S, Smith C, Pal S

Interpretable deep learning survival predictions in sporadic Creutzfeldt-Jakob disease.

J Neurol. 2024 Dec 16;272(1):62. PubMed.

PAPER Raposo Pereira F, Chaumon M, Dubois B, Bakardjian H, Bahrami M, Habert MO, Andrade K, Younsi N, La Corte V, George N, INSIGHT-preAD study group

Recognition memory decline is associated with the progression to prodromal Alzheimer's disease in asymptomatic at-risk individuals.

J Neurol. 2024 Dec 16;272(1):70. PubMed.

PAPER De Houwer JF, Dopper EG, Rajicic A, van Buuren R, Arcaro M, Galimberti D, Breedveld GJ, Wilke M, van Minkelen R, Jiskoot LC, van Swieten JC, Donker Kaat L, Seelaar H

Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history.

J Neurol. 2024 Dec 16;272(1):64. PubMed.

PAPER Subramanian I, Saad A

Heatwaves and Neurodegenerative Disease.

JAMA Neurol. 2024 Dec 16; Epub 2024 Dec 16 PubMed.

PAPER Liu H, Zhao XF, Lu YN, Hayes LR, Wang J

CRISPR/Cas13d targeting suppresses repeat-associated non-AUG translation of C9orf72 hexanucleotide repeat RNA.

J Clin Invest. 2024 Dec 16;134(24) PubMed. Corrected paper.

PAPER Meng J, Lei P

Testing cognitive normal for Alzheimer's disease prediction.

J Neurochem. 2025 Jan;169(1):e16272. PubMed.

Dena Davis

United States

Anne Wienand

PAPER Xu F, Huang H, Feng J, Shen Q, Bao Y, Zhang D, Xu Y

Cerebrospinal fluid tau and disease progression in early Parkinson's disease: an 8-year longitudinal study.

J Neurol. 2024 Dec 16;272(1):61. PubMed.

PAPER Liu Y, Wang J, Ning F, Wang G, Xie A

Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease.

Clin Transl Sci. 2024 Dec;17(12):e70111. PubMed.

PAPER Rose S, Gergoire A, Pal S, Reader J, Bhaumik A, Slotkin J, Ho E, Nowinski CJ, Persad CC, Maher AC, Weintraub S, Gershon R, Giordani B

Evaluating the factor structure and construct validity of the NIH toolbox in older adults, with a focus on cognitive normalcy and amnestic mild cognitive impairment: considerations for diversity, including insights from persons over 85 years of age and Bl

J Int Neuropsychol Soc. 2024 Dec 16;:1-6. Epub 2024 Dec 16 PubMed.

PAPER Zimyanin V, Dash BP, Großmann D, Simolka T, Glaß H, Verma R, Khatri V, Deppmann C, Zunder E, Redemann S, Hermann A

Axonal transcriptome reveals upregulation of PLK1 as a protective mechanism in response to increased DNA damage in FUS P525L spinal motor neurons.

bioRxiv. 2024 Nov 21; PubMed.